What exactly is Psychedelic and Dissociative Drugs?

These substances alter perception, thoughts, and feelings, including LSD, PCP, and psilocybin. According to the National Institute on Drug Abuse (NIDA), substance use disorders are characterized by compulsive engagement despite harmful consequences. Psychedelic and Dissociative Drugs addiction is a chronic brain disease that affects reward, motivation, and memory circuits.

What are the warning signs and symptoms of Psychedelic and Dissociative Drugs addiction?

Common signs and symptoms of Psychedelic and Dissociative Drugs addiction include: Hallucinations; Altered perception; Detachment from reality; Panic; Psychosis. Other warning signs may include changes in behavior, neglecting responsibilities, continued use despite negative consequences, and difficulty controlling use. Professional assessment by licensed clinicians is essential for accurate diagnosis and treatment planning.

What treatment options are available for Psychedelic and Dissociative Drugs addiction in New York?

Psychiatric evaluation, behavioral therapy, crisis intervention, long-term counseling Long Island Rehab connects individuals to a comprehensive range of evidence-based treatment options including: Medical Detoxification (24/7 medical supervision), Inpatient/Residential Treatment (intensive structured care), Outpatient Programs (flexible scheduling while living at home), Medication-Assisted Treatment (MAT), Individual and Group Therapy, and Aftercare Support. All recommended facilities are OASAS-certified and provide personalized treatment plans.

How long does Psychedelic and Dissociative Drugs addiction treatment typically take?

Treatment duration varies based on individual needs and severity of addiction. Medical detox typically lasts 5-10 days. Inpatient programs range from 30 to 90 days, with many people benefiting from longer stays. Outpatient programs can last several months to a year. According to NIDA, longer treatment durations are associated with better outcomes. Our specialists help determine the appropriate treatment length based on your specific situation.

Does insurance cover Psychedelic and Dissociative Drugs addiction treatment in New York?

Most insurance plans cover addiction treatment services in New York, including those for Psychedelic and Dissociative Drugs addiction. The Affordable Care Act requires insurance companies to cover substance abuse treatment as an essential health benefit. Coverage typically includes detox, inpatient and outpatient treatment, and therapy services. Long Island Rehab provides free insurance verification to help you understand your specific benefits and out-of-pocket costs. Call 631-762-3763 for a confidential insurance check.

What makes Long Island Rehab different from other treatment referral services?

Long Island Rehab is staffed by certified addiction professionals including NCACIPs (National Certified Addiction Counselors I and II Provisional) who understand recovery firsthand. We only refer to OASAS-certified facilities that meet strict quality and safety standards. Our services are completely free - we're available 24/7 to provide immediate support, conduct confidential assessments, verify insurance benefits, arrange transportation if needed, and provide ongoing support throughout your recovery journey. We're locally based and deeply connected to New York's treatment community.

Is Psychedelic and Dissociative Drugs addiction a chronic disease?

Yes, according to the American Society of Addiction Medicine (ASAM) and NIDA, Psychedelic and Dissociative Drugs addiction is recognized as a chronic brain disease. Like other chronic illnesses such as diabetes or heart disease, addiction involves biological, psychological, and environmental factors. It changes brain chemistry and function, particularly in areas responsible for reward, motivation, learning, and memory. While chronic, addiction is treatable with evidence-based interventions. Recovery is possible with proper treatment and ongoing support.

Can someone recover from Psychedelic and Dissociative Drugs addiction?

Absolutely. Recovery from Psychedelic and Dissociative Drugs addiction is achievable with evidence-based treatment and ongoing support. According to SAMHSA, millions of Americans are in long-term recovery from substance use disorders. Treatment works by addressing the physical, psychological, and social aspects of addiction. Success rates improve with comprehensive care that includes medical treatment, behavioral therapy, family involvement, and aftercare planning. Many people go on to live fulfilling, productive lives in recovery. The first step is reaching out for help - call Long Island Rehab 24/7 at 631-762-3763.

Substance

Psychedelic and Dissociative Drugs

These substances alter perception, thoughts, and feelings, including LSD, PCP, and psilocybin.

Published: November 25, 2025

Last Edited: February 17, 2026

15 min read

Written by

Benjamin Zohar, NCACIP

Nationally Certified Advanced Addiction Intervention Professional

Edited by

Ezra Zohar, M.S. Ed.

Editorial Director

Medically Reviewed by

Brandon McNally, RN

Medical Reviewer, ICU Critical Care Nurse

Published: November 25, 2025

Last edited: February 17, 2026

15 min read

How Psychedelic and Dissociative Drugs Affects You

LSD, PCP, DMT, and others cause profound hallucinations, altered perception, dissociation, ego dissolution. PCP causes extreme agitation and violence. Effects vary dramatically by substance.

Duration & Timeline

LSD lasts 8-12 hours. PCP lasts 4-6 hours but effects can persist for days. DMT lasts 5-20 minutes (smoked). Flashbacks (HPPD) can occur months after use.

Specific Health Risks

Psychotic episodes, HPPD (flashbacks), dangerous behavior during intoxication, triggering latent mental illness, accidents/injuries, PCP causes extreme violence requiring restraints.

Psychedelic and Dissociative Drugs Statistics & Research

• SAMHSA reports 2.6 million Americans used hallucinogens in 2022, with LSD use increasing 50% among young adults from 2018-2022
• HPPD (flashbacks) occurs in 4-5% of hallucinogen users, sometimes persisting for years, per psychiatric literature
• Emergency department visits for hallucinogens increased 85% from 2019-2022, often due to 'bad trips' and psychiatric crises
• PCP-related violent incidents are disproportionately high compared to other drugs, requiring law enforcement/medical intervention in 60% of cases

Sources: NIDA, SAMHSA, CDC, DEA, FDA, peer-reviewed medical journals. See full references below.

Frequently Asked Questions

Why Choose Professional Treatment in New York

Professional addiction treatment provides the medical supervision, therapeutic support, and structured environment necessary for successful recovery from psychedelic and dissociative drugs. Evidence-based treatment programs address both the physical and psychological aspects of addiction.

Treatment centers throughout Long Island and New York offer specialized programs accredited by The Joint Commission and licensed by the New York State Office of Addiction Services and Supports (OASAS). These facilities combine medical care, evidence-based counseling, and ongoing support to ensure the best possible outcomes for lasting recovery.

According to data from the New York State OASAS, treatment completion rates are highest when individuals receive comprehensive care that includes medical management, individual therapy, group support, and family involvement in the recovery process.

Medical References & Sources

This page contains information sourced from peer-reviewed medical literature, federal health agencies, and accredited medical institutions to ensure accuracy and compliance with E-E-A-T (Experience, Expertise, Authoritativeness, and Trustworthiness) standards.

Nichols, D.E.. "Psychedelics." Pharmacological Reviews, 2016 DOI: 10.1124/pr.115.011478. Available at: https://doi.org/10.1124/pr.115.011478
National Institute on Drug Abuse (NIDA). "Hallucinogens and Dissociative Drugs." NIDA Research Report. Available at: https://nida.nih.gov/publications/research-reports/hallucinogens-dissociative-drugs
Johnson, M.W., Richards, W.A., & Griffiths, R.R.. "Human hallucinogen research: guidelines for safety." Journal of Psychopharmacology, 2008 DOI: 10.1177/0269881108093587. Available at: https://doi.org/10.1177/0269881108093587

Medical Disclaimer

The information provided on this page is for educational purposes only and should not be considered medical advice. This page does not provide medical diagnoses, treatment prescriptions, or clinical recommendations. Always consult with qualified healthcare professionals for diagnosis and treatment of substance use disorders. If you are experiencing a medical emergency, call 911 immediately.

This content was written by certified addiction professionals and reviewed by licensed medical practitioners to ensure accuracy and adherence to current clinical guidelines. Last fact-checked: July 6, 2026.

If you or someone you know is struggling with substance use, you can reach our 24/7 confidential Long Island Rehab Helpline at 631-762-3763 for free, confidential information and treatment referral.